For the Inventor, By the Inventor

Enter assignee name

Camurus Ab

USPTO Granted Patents = 39

CIPO Patents = 63

EPO Patents = 26

Trademarks = 17

Forward Citations = 275

Loading Chart...

Loading Chart...

35 inventors (with patents filed for the assignee):

Fredrik Tiberg (32 out of 34 patents)

Markus Johnsson (32 out of 35 patents)

Catalin Nistor (12 out of 13 patents)

4. Fredrik Joabsson (12 out of 13 patents)

5. Ian Harwigsson (10 out of 11 patents)

6. Justas Barauskas (7 out of 8 patents)

7. Krister Thuresson (7 out of 9 patents)

8. Margareta Linden (3 out of 3 patents)

9. Markus Johansson (2 out of 3 patents)

10. Kare V Larsson (2 out of 14 patents)

11. Britta Siekmann (1 out of 2 patents)

12. Gert Wörle (1 out of 1 patent)

13. Heike Bunjes (1 out of 1 patent)

14. Hakan Hakansson (1 out of 5 patents)

15. Andreas Norlin (1 out of 1 patent)

39 patents: Sort by Forward Citations

1. 12396944 - Injectable buprenorphine formulation (2025-08-26),

2. 12318379 - Opioid formulations (2025-06-03),

3. 12246055 - Lipid-controlled release compositions (2025-03-11),

4. 12161640 - Opioid formulations (2024-12-10),

5. 12029813 - Injectable buprenorphine formulation (2024-07-09),

6. 11672843 - Somatostatin receptor agonist formulations (2023-06-13),

7. 11564968 - Formulations containing a somatostatin receptor agonist (2023-01-31),

8. 11433120 - Controlled release peptide formulations (2022-09-06),

9. 11369617 - Prostacyclin analogue formulations (2022-06-28),

10. 11241476 - Mixtures and formulations comprising an alkyl ammonium EDTA salt (2022-02-08),

11. 11135264 - Formulations containing a somatostatin receptor agonist (2021-10-05),

12. 11135215 - Opioid formulations (2021-10-05),

13. 11110084 - Opioid formulations (2021-09-07),

14. 10912772 - Opioid formulations (2021-02-09),

15. 10688148 - Formulations containing a somatostatin receptor agonist (2020-06-23),

Camurus AB is a Swedish research-based pharmaceutical company specializing in the development and commercialization of innovative and long-acting medicines for the treatment of severe and chronic conditions. Their portfolio includes products for pain management, addiction treatment, and cancer supportive care. With a focus on advanced drug delivery technologies, Camurus aims to improve patient outcomes and quality of life.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

39 Patents

#15 in Lund

#168 in Sweden

#16,936 in the World

Camurus Ab

Forward Citations = 275

35 inventors:

Fredrik Tiberg (32 out of 34 patents)

Markus Johnsson (32 out of 35 patents)

Catalin Nistor (12 out of 13 patents)

4. Fredrik Joabsson (12 out of 13 patents)

5. Ian Harwigsson (10 out of 11 patents)

Please report any incorrect information to support@idiyas.com

Loading…